Trial Update July 21, 2026

VIP-Linked Trial "TEAS-TIME" Registered, Not Yet Recruiting as of July 2026

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

A clinical trial registry entry involving vasoactive intestinal peptide was updated on July 21, 2026. The trial, titled "TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)," is registered under identifier NCT07714980.

According to the registry, the trial's current status is listed as "not yet recruiting." The phase for this study is listed as not applicable.

No additional details about design, timeline, or objectives were included in this update. No results have been posted for this trial. The registry entry does not state when recruitment is expected to begin.

As with any trial that has not yet started recruitment, further updates would be needed to confirm enrollment status, site activation, or any changes to the study protocol. Readers should treat this listing as a registration event only, reflecting the trial's status as recorded on the date noted above.

For more background on vasoactive intestinal peptide, including its approved regulatory status, see the compound overview.

See the full vasoactive intestinal peptide overview

Source: https://clinicaltrials.gov/study/NCT07714980